Ultrafast real time q-PCR relying on microfluidic thermalization – FASTGENE
Real time qPCR is today the most powerful tool for genetic detection of biological warfare agents. Commercial systems are also used as reference for medical diagnostics and for bio-threat identification. FASTGENE project aims at developing a new technology to decrease the time required for a typical analysis of targeted bio-agents from 30 min to 5 min while keeping the detection threshold of best commercial systems. The proof of concept of such a technological and scientific breakthrough will rely on a patented ultra fast microfluidic system for biosample thermalization originally developped for cell biology studies. Based on this technology , a new configuration will be designed and optimized in order to perform temperature changes less than 0.1s in the range between 30°C and 95°C. This platform will be developped in accordance with portability issues required for field operations and local detection of pathogen agents. In order to get a valuable proof of concept, the 5min detection of a biological agent simulating the Anthrax will be targeted by a consortium of ENS research group (inventor of the technology) and ELVESYS Start-up company (owner of an exclusive licence).
Project coordination
Adrien PLECIS (ELVESYS) – astrid@elvesys.com
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
ELVESYS
ENS ECOLE NORMALE SUPERIEURE
Help of the ANR 295,371 euros
Beginning and duration of the scientific project:
January 2011
- 30 Months